Loading provider…
Loading provider…
Radiation Oncology Physician in Baltimore, MD
NPI: 1265876973Primary Practice Location
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore, MD
Primary Employer
University of Maryland Radiation Oncology Associates PA
cmradonc.org
HQ Phone
Get M.D. Jason's Phone Numberphone_androidMobile
Get M.D. Jason's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
MD State Medical License
2018 - 2025

American Board of Radiology
Radiation Oncology
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 2013
University of Maryland
Residency • Radiation Oncology
2014 - 2018
Greater Baltimore Medical Center
Residency • Internal Medicine
2013 - 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77014Ct scan guidance for insertion of radiation therapy fields | 168 | 280 |
| 2 | 77523Proton treatment delivery, intermediate | 151 | 260 |
| 3 | 77263Complex radiation therapy planning | 120 | 127 |
| 4 | 77427Radiation treatment management, 5 treatment sessions | 112 | 327 |
| 5 | G6002Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 96 | 152 |
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Authors: Daniel Spratt, Philip Sutera, Mark Mishra, Matthew Ferris, Amar Kishan, Phuoc Tran, Matthew Deek, Young Kwok
Journal: Prostate
Proton Beam Therapy in Liver Malignancies
Lead Sponsor: University of Maryland, Baltimore
Intervention / Treatment: OTHER: Experimental Observation, OTHER: Observation per Standard of Care, RADIATION: Adjuvant Treatment per Standard of Care, DIAGNOSTIC_TEST: Circulating Tumor DNA test (ctDNA test)
Lead Sponsor: University of Maryland, Baltimore
Intervention / Treatment: DRUG: Gemcitabine, RADIATION: Hypofractionated Ablative Proton Therapy
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI), National Institute of Dental and Craniofacial Research (NIDCR)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: Proton Beam Radiation Therapy, RADIATION: Photon Beam Radiation Therapy